Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis
Molecular Typing of Adult Community-acquired Pneumonia in China
Sponsor: CapitalBio Group Corporation
A observational or N/A phase clinical study on Community-Acquired Infections and Genetic Disorder, this trial is ongoing. The trial is conducted by CapitalBio Group Corporation and has accumulated 11 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Apr 2019 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
May 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CapitalBio Group Corporation
- Chinese Academy of Sciences
- Peking University People's Hospital
- Second Hospital of Jilin University
- Shanghai Pulmonary Hospital, Shanghai, China
- West China Hospital
For direct contact, visit the study record on ClinicalTrials.gov .